Work

High dose toremifene for estrogen and progesterone receptor negative metastatic breast cancer: A phase II trial of the Cancer and Leukemia Group B (CALGB)

Year: 1995

Type: article

Study design: Clinical Trial

Source: Breast Cancer Research and Treatment

DOI: 10.1007/bf00690182

Authors: James J. Perry, Donald A. Berry, Raymond B. Weiss, Daniel M. Hayes, David B. Duggan, I. Craig Henderson

Institutions: Wake Forest Baptist Comprehensive Cancer Center, Wake Forest University, Walter Reed National Military Medical Center, Dana-Farber Cancer Institute, SUNY Upstate Medical University, University of California, San Francisco

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: LOEWE Zentrum AdRIA, National Cancer Institute

Awards: CANCER AND LEUKEMIA GROUP B, G237383067, Cancer and Leukemia Group B, G2647518335, Cancer and Leukemia Group B Statistical Center, G4670716055

OpenAlex ID: W2043309754

FWCI: 0.659

Cites: 19

Cited by: 8

Related to: 10